Entia Biosciences, Inc (OTCPK:ERGO) announced a private placement of 4,750,000 at a price of $0.10 per share for gross proceeds of $475,000 on July 29, 2015. Each unit consists of one common share and one warrant A and warrant B. Each warrant A entitles the holder to purchase one common share of the company at an exercise price of $0.125 per share for a period of three years from the date of closing, warrant B to purchase one share of common stock at an exercise price of $0.15 per share. The transaction included participation from 16 accredited investors.

The company has issued securities pursuant to exemption provided under Regulation D.